Abiopharma

🔍 ROLLINS JAMES D III (Director)

Company: HUNTINGTON BANCSHARES INC /MD/ (HBAN)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Acquired 6,500 shares of Dep Shares-int in 4.50% Ser H Non-Cum Perp Pref Stk at $17.09 per share (Direct)
  Date: 2026-04-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 11,500.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,971 shares of Dep Shares-int in 5.50% Ser L Non-Cum Perp Pref Stk at $21.05 per share (Direct)
  Date: 2026-04-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 6,471.00 | transaction_form_type: 4
• Acquired 3,029 shares of Dep Shares-int in 5.50% Ser L Non-Cum Perp Pref Stk at $21.05 per share (Direct)
  Date: 2026-04-28 | Code: P | equity_swap_involved: 0 | shares_owned_after: 9,500.00 | transaction_form_type: 4

Footnotes:

• F1: This transaction was executed in multiple trades ranging from $17.08 to $17.10. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.